Indivior Pharmaceuticals Inc
INDV
Ранг среди акций
#4005
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Цена акции
$32.56
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$4.06B
Изменение (1 день)
-3.15%
Изменение (1 год)
33.01%
Страна
US
Торговля Indivior Pharmaceuticals Inc (INDV)
Категория
Healthcare
EPS для Indivior Pharmaceuticals Inc (INDV)
EPS по состоянию на June 2026 TTM: $2.84
Согласно последним финансовым отчетам и цене акций Indivior Pharmaceuticals Inc, текущий EPS компании (TTM) составляет $2.84. В конце 2023 EPS компании составлял $0.01, больше, чем показателю 2022 года, равному $-0.37.
История EPS компании Indivior Pharmaceuticals Inc с 2016 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
